請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/55222
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 邱麗珠 | |
dc.contributor.author | Rui-Shan Kang | en |
dc.contributor.author | 康瑞珊 | zh_TW |
dc.date.accessioned | 2021-06-16T03:52:02Z | - |
dc.date.available | 2020-03-12 | |
dc.date.copyright | 2015-03-12 | |
dc.date.issued | 2015 | |
dc.date.submitted | 2015-01-15 | |
dc.identifier.citation | Agarwal N et al. (2007) Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nature neuroscience 10:870-879.
Akil H, Mayer DJ, Liebeskind JC (1976) Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist. Science (New York, NY) 191:961-962. Amitani M, Umetani Y, Hosoi R, Kobayashi K, Abe K, Inoue O (2005) Changes in in vivo [(3)H]-Ro15-4513 binding induced by forced swimming in mice. Synapse 58:23-29. Azhdari-Zarmehri H, Semnanian S, Fathollahi Y (2014) Orexin-A microinjection into the rostral ventromedial medulla causes antinociception on formalin test. Pharmacology, biochemistry, and behavior 122:286-290. Azhdari Zarmehri H, Semnanian S, Fathollahi Y, Erami E, Khakpay R, Azizi H, Rohampour K (2011) Intra-periaqueductal gray matter microinjection of orexin-A decreases formalin-induced nociceptive behaviors in adult male rats. The journal of pain : official journal of the American Pain Society 12:280-287. Bannon AW, Malmberg AB (2007) Models of nociception: hot-plate, tail-flick, and formalin tests in rodents. Current protocols in neuroscience / editorial board, Jacqueline N Crawley [et al] Chapter 8:Unit 8 9. Barrot M (2012) Tests and models of nociception and pain in rodents. Neuroscience 211:39-50. Basbaum AI, Fields HL (1978) Endogenous pain control mechanisms: review and hypothesis. Annals of neurology 4:451-462. Behbehani MM (1995) Functional characteristics of the midbrain periaqueductal gray. Progress in neurobiology 46:575-605. Beitz AJ, Shepard RD (1985) The midbrain periaqueductal gray in the rat. II. A Golgi analysis. The Journal of comparative neurology 237:460-475. Bingham S, Davey PT, Babbs AJ, Irving EA, Sammons MJ, Wyles M, Jeffrey P, Cutler L, Riba I, Johns A, Porter RA, Upton N, Hunter AJ, Parsons AA (2001) Orexin-A, an hypothalamic peptide with analgesic properties. Pain 92:81-90. Butler RK, Finn DP (2009) Stress-induced analgesia. Progress in neurobiology 88:184-202. Butler RK, Rea K, Lang Y, Gavin AM, Finn DP (2008) Endocannabinoid-mediated enhancement of fear-conditioned analgesia in rats: opioid receptor dependency and molecular correlates. Pain 140:491-500. Butler RK, Ford GK, Hogan M, Roche M, Doyle KM, Kelly JP, Kendall DA, Chapman V, Finn DP (2012) Fear-induced suppression of nociceptive behaviour and activation of Akt signalling in the rat periaqueductal grey: role of fatty acid amide hydrolase. Journal of psychopharmacology 26:83-91. Calignano A, La Rana G, Giuffrida A, Piomelli D (1998) Control of pain initiation by endogenous cannabinoids. Nature 394:277-281. Chang LY (2010) Endogenous orexins contribute to stress-induced analgesia through endocannabinoid retrograde signaling in the ventrolateral periaqueductal gray. In. Cheng JK, Chou RC, Hwang LL, Chiou LC (2003) Antiallodynic effects of intrathecal orexins in a rat model of postoperative pain. The Journal of pharmacology and experimental therapeutics 307:1065-1071. Chiou LC, Teng SF, Chang LY (2010a) Restraint stress induces analgesia through endogenous orexins via OX1 receptor-mediated endocannabinoid retrograde disinhibition in the ventrolateral periaqueductal gray. In: Neuroscience 2010, p Prog. No. 844.841. San Diego, USA. Chiou LC, Hu SS, Ho YC (2013) Targeting the cannabinoid system for pain relief? Acta anaesthesiologica Taiwanica : official journal of the Taiwan Society of Anesthesiologists 51:161-170. Chiou LC, Lee HJ, Ho YC, Chen SP, Liao YY, Ma CH, Fan PC, Fuh JL, Wang SJ (2010b) Orexins/hypocretins: pain regulation and cellular actions. Current pharmaceutical design 16:3089-3100. Chipkin RE, Latranyi MB, Iorio LC (1982) Potentiation of stress-induced analgesia (SIA) by thiorphan and its block by naloxone. Life sciences 31:1189-1192. Connell K, Bolton N, Olsen D, Piomelli D, Hohmann AG (2006) Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia. Neurosci Lett 397:180-184. Contet C, Gaveriaux-Ruff C, Matifas A, Caradec C, Champy MF, Kieffer BL (2006) Dissociation of analgesic and hormonal responses to forced swim stress using opioid receptor knockout mice. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 31:1733-1744. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS, 2nd, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proceedings of the National Academy of Sciences of the United States of America 95:322-327. De Luca-Vinhas MC, Macedo CE, Brandao ML (2006) Pharmacological assessment of the freezing, antinociception, and exploratory behavior organized in the ventrolateral periaqueductal gray. Pain 121:94-104. de Luca MC, Brandao ML, Motta VA, Landeira-Fernandez J (2003) Antinociception induced by stimulation of ventrolateral periaqueductal gray at the freezing threshold is regulated by opioid and 5-HT2A receptors as assessed by the tail-flick and formalin tests. Pharmacology, biochemistry, and behavior 75:459-466. Dzambazova EB, Landzhov BV, Bocheva AI, Bozhilova-Pastirova AA (2011) Effects of D-kyotorphin on nociception and NADPH-d neurons in rat's periaqueductal gray after immobilization stress. Amino acids 41:937-944. Finn DP, Beckett SR, Richardson D, Kendall DA, Marsden CA, Chapman V (2004) Evidence for differential modulation of conditioned aversion and fear-conditioned analgesia by CB1 receptors. Eur J Neurosci 20:848-852. Franklin K, Paxinos G (1997) The mouse brain in stereotaxic coordinates, 1997. Academic, San Diego. Gehani NC, Nalwalk JW, Razdan RK, Martin BR, Sun X, Wentland M, Abood ME, Hough LB (2007) Significance of cannabinoid CB1 receptors in improgan antinociception. The journal of pain : official journal of the American Pain Society 8:850-860. Gerashchenko D, Horvath TL, Xie XS (2011) Direct inhibition of hypocretin/orexin neurons in the lateral hypothalamus by nociceptin/orphanin FQ blocks stress-induced analgesia in rats. Neuropharmacology 60:543-549. Girardot MN, Holloway FA (1984) Intermittent cold water stress-analgesia in rats: cross-tolerance to morphine. Pharmacology, biochemistry, and behavior 20:631-633. Greenberg R, O'Keefe EH (1982) Thiorphan potentiation of stress-induced analgesia in the mouse. Life sciences 31:1185-1188. Hama A, Sagen J (2011) Centrally mediated antinociceptive effects of cannabinoid receptor ligands in rat models of nociception. Pharmacology, biochemistry, and behavior 100:340-346. Harris JA (1996) Descending antinociceptive mechanisms in the brainstem: their role in the animal's defensive system. Journal of physiology, Paris 90:15-25. Hart SL, Slusarczyk H, Smith TW (1983) The involvement of opioid delta-receptors in stress induced antinociception in mice. European journal of pharmacology 95:283-285. Heidari-Oranjaghi N, Azhdari-Zarmehri H, Erami E, Haghparast A (2012) Antagonism of orexin-1 receptors attenuates swim- and restraint stress-induced antinociceptive behaviors in formalin test. Pharmacology, biochemistry, and behavior 103:299-307. Helmstetter FJ, Tershner SA (1994) Lesions of the periaqueductal gray and rostral ventromedial medulla disrupt antinociceptive but not cardiovascular aversive conditional responses. The Journal of neuroscience : the official journal of the Society for Neuroscience 14:7099-7108. Ho YC, Lee HJ, Tung LW, Liao YY, Fu SY, Teng SF, Liao HT, Mackie K, Chiou LC (2011) Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition. The Journal of neuroscience : the official journal of the Society for Neuroscience 31:14600-14610. Hohmann AG, Suplita RL, Bolton NM, Neely MH, Fegley D, Mangieri R, Krey JF, Walker JM, Holmes PV, Crystal JD, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D (2005) An endocannabinoid mechanism for stress-induced analgesia. Nature 435:1108-1112. Hough LB, de Esch IJ, Janssen E, Phillips J, Svokos K, Kern B, Trachler J, Abood ME, Leurs R, Nalwalk JW (2006) Antinociceptive activity of chemical congeners of improgan: optimization of side chain length leads to the discovery of a new, potent, non-opioid analgesic. Neuropharmacology 51:447-456. Jorgensen HA, Fasmer OB, Berge OG, Tveiten L, Hole K (1984) Immobilization-induced analgesia: possible involvement of a non-opioid circulating substance. Pharmacology, biochemistry, and behavior 20:289-292. Khodayar MJ, Shafaghi B, Naderi N, Zarrindast MR (2006) Antinociceptive effect of spinally administered cannabinergic and 2-adrenoceptor drugs on the formalin test in rat: possible interactions. Journal of psychopharmacology 20:67-74. Kurrikoff K, Inno J, Matsui T, Vasar E (2008) Stress-induced analgesia in mice: evidence for interaction between endocannabinoids and cholecystokinin. Eur J Neurosci 27:2147-2155. Lau BK, Drew GM, Mitchell VA, Vaughan CW (2014) Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey. British journal of pharmacology 171:5225-5236. Lewis JW, Cannon JT, Liebeskind JC (1980) Opioid and nonopioid mechanisms of stress analgesia. Science (New York, NY) 208:623-625. Li N, Han ZL, Fang Q, Wang ZL, Tang HZ, Ren H, Wang R (2012) Neuropeptide FF and related peptides attenuates warm-, but not cold-water swim stress-induced analgesia in mice. Behavioural brain research 233:428-433. Marchand F, Perretti M, McMahon SB (2005) Role of the immune system in chronic pain. Nature reviews Neuroscience 6:521-532. Menendez L, Andres-Trelles F, Hidalgo A, Baamonde A (1993) Involvement of spinal kappa opioid receptors in a type of footshock induced analgesia in mice. Brain research 611:264-271. Mobarakeh JI, Takahashi K, Sakurada S, Nishino S, Watanabe H, Kato M, Yanai K (2005) Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and -2) in mice. Peptides 26:767-777. Mogil JS, Belknap JK (1997) Sex and genotype determine the selective activation of neurochemically-distinct mechanisms of swim stress-induced analgesia. Pharmacology, biochemistry, and behavior 56:61-66. Murray CW, Porreca F, Cowan A (1988) Methodological refinements to the mouse paw formalin test. An animal model of tonic pain. Journal of pharmacological methods 20:175-186. Naderi N, Majidi M, Mousavi Z, Khoramian Tusi S, Mansouri Z, Khodagholi F (2012) The interaction between intrathecal administration of low doses of palmitoylethanolamide and AM251 in formalin-induced pain related behavior and spinal cord IL1-beta expression in rats. Neurochemical research 37:778-785. Olango WM, Roche M, Ford GK, Harhen B, Finn DP (2012) The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone. British journal of pharmacology 165:2549-2560. Oluyomi AO, Hart SL (1990) Alpha-adrenoceptor involvement in swim stress-induced antinociception in the mouse. The Journal of pharmacy and pharmacology 42:778-784. Onodera K, Sakurada S, Furuta S, Yonezawa A, Arai K, Hayashi T, Katsuyama S, Sato T, Miyazaki S, Kisara K (2000) Differential involvement of opioid receptors in stress-induced antinociception caused by repeated exposure to forced walking stress in mice. Pharmacology 61:96-100. Parolaro D, Massi P, Patrini G, Rubino T, Parenti M, Gori E (1991) Pertussis toxin pretreatment affects opiate/nonopiate and stress-induced analgesia differently. Pharmacology, biochemistry, and behavior 38:569-573. Pertwee RG (2001) Cannabinoid receptors and pain. Progress in neurobiology 63:569-611. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. The Journal of neuroscience : the official journal of the Society for Neuroscience 18:9996-10015. Przewlocka B, Sumova A, Lason W (1990) The influence of conditioned fear-induced stress on the opioid systems in the rat. Pharmacology, biochemistry, and behavior 37:661-666. Richardson JD, Aanonsen L, Hargreaves KM (1997) SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice. European journal of pharmacology 319:R3-4. Richardson JD, Aanonsen L, Hargreaves KM (1998) Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia. The Journal of neuroscience : the official journal of the Society for Neuroscience 18:451-457. Rizzi A, Marzola G, Bigoni R, Guerrini R, Salvadori S, Mogil JS, Regoli D, Calo G (2001) Endogenous nociceptin signaling and stress-induced analgesia. Neuroreport 12:3009-3013. Rubinstein M, Mogil JS, Japon M, Chan EC, Allen RG, Low MJ (1996) Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis. Proceedings of the National Academy of Sciences of the United States of America 93:3995-4000. Sakurada S, Onodera K, Katsuyama S, Yonezawa A, Arai K, Hayashi T, Furuta S, Sato T, Kisara K (1999) Effects of forced walking stress on formalin-induced paw licking in mice. Methods and findings in experimental and clinical pharmacology 21:467-470. Sakurai T et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573-585. Seo YJ, Kwon MS, Choi SM, Lee JK, Park SH, Jung JS, Sim YB, Suh HW (2011) Differential cross-tolerance development between single and repeated immobilization stress on the antinociceptive effect induced by beta-endorphin, 5-hydroxytryptamine, morphine, and WIN55,212-2 in the inflammatory mouse pain mode. Archives of pharmacal research 34:269-280. Shibata M, Ohkubo T, Takahashi H, Inoki R (1989) Modified formalin test: characteristic biphasic pain response. Pain 38:347-352. Strangman NM, Patrick SL, Hohmann AG, Tsou K, Walker JM (1998) Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity. Brain research 813:323-328. Suplita RL, 2nd, Farthing JN, Gutierrez T, Hohmann AG (2005) Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla. Neuropharmacology 49:1201-1209. Suplita RL, 2nd, Gutierrez T, Fegley D, Piomelli D, Hohmann AG (2006) Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia. Neuropharmacology 50:372-379. Takahashi M, Tokuyama S, Kaneto H (1987) Implication of endogenous opioid mechanism in the production of the antinociceptive effect induced by psychological stress in mice. Japanese journal of pharmacology 44:283-291. Tsujino N, Sakurai T (2009) Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacological reviews 61:162-176. Tung LW, Chang LY, Lu GL, Yu L, Teng SF, Hung MS, Mackie K, Zimmer A, Chiou LC (2013) A novel mechanism for stress-induced relapse of cocaine seeking: Orexin 1 receptor-initiated eCB retrograde disinhibition of VTA dopaminergic neurons. In: International Conference on Global Health 2013. Taipei, Taiwan. Valverde O, Ledent C, Beslot F, Parmentier M, Roques BP (2000) Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors. The European journal of neuroscience 12:533-539. Watanabe S, Kuwaki T, Yanagisawa M, Fukuda Y, Shimoyama M (2005) Persistent pain and stress activate pain-inhibitory orexin pathways. Neuroreport 16:5-8. Watkins LR, Cobelli DA, Faris P, Aceto MD, Mayer DJ (1982) Opiate vs non-opiate footshock-induced analgesia (FSIA): the body region shocked is a critical factor. Brain research 242:299-308. Watkins LR, Wiertelak EP, Grisel JE, Silbert LH, Maier SF (1992) Parallel activation of multiple spinal opiate systems appears to mediate 'non-opiate' stress-induced analgesias. Brain research 594:99-108. Xie X, Wisor JP, Hara J, Crowder TL, LeWinter R, Khroyan TV, Yamanaka A, Diano S, Horvath TL, Sakurai T, Toll L, Kilduff TS (2008) Hypocretin/orexin and nociceptin/orphanin FQ coordinately regulate analgesia in a mouse model of stress-induced analgesia. The Journal of clinical investigation 118:2471-2481. Yamamoto T, Nozaki-Taguchi N, Chiba T (2002) Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot plate test. British journal of pharmacology 137:170-176. Yamamoto T, Saito O, Shono K, Hirasawa S (2003) Activation of spinal orexin-1 receptor produces anti-allodynic effect in the rat carrageenan test. European journal of pharmacology 481:175-180. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/55222 | - |
dc.description.abstract | 食慾素 (orexin) 系統由兩種神經胜肽 (食慾素A和食慾素B) 和兩種Gq蛋白偶合受體 (Gq-protein-coupled receptors; GqPCRs),食慾素1受體 (orexin 1 receptor; OX1R) 和食慾素2受體 (orexin 2 receptor; OX2R)。食慾素,也稱做下視丘素(hypocretin),是種下視丘胜肽,已經被研究出有止痛效果。先前我們已經發現在中腦環導水管灰質腹外側區 (ventrolateral periaqueductal gray; vlPAG) 活化食慾素1受體,能夠藉由內生性大麻酯之一的2-arachidonoylglycerol (2-AG)作用於γ-氨基丁酸 (γ-aminobutyric acid; GABA) 神經終端突觸上的大麻酯1受體 (cannabinoid 1 receptor; CB1R) 而抑制GABA釋放,於同個核區內進行逆行性去抑制 (disinhibition) 現象,進而活化下行性疼痛抑制路徑,產生止痛效果。
緊張所致止痛 (stress induced analgesia; SIA) 是一種哺乳類的演化保護機制,用來處理緊張的狀況。各式各樣的壓力源可以抑制生物體對傷害性疼痛刺激的反應。急性束縛壓力 (acute restraint stress),引發止痛的壓力源之一,已經被報導可以經由食慾素調節機制來止痛。在我們先前的研究中,發現對小鼠進行三十分鐘的束縛壓力可以在熱板實驗上呈現止痛效果,而這樣的緊張所致止痛現象可以被vlPAG內注射的OX1R和CB1R拮抗劑所阻斷。 在本篇論文中,我們研究在由周邊發炎和接續的中樞促敏感性調控的福馬林疼痛實驗上,對小鼠進行三十分鐘的束縛壓力是否依然可呈現止痛效果,而此效果是否依然由位於vlPAG的食慾素和內生性大麻酯調控。 首先,對小鼠進行三十分鐘的束縛壓力在福馬林實驗第二期呈現止痛效果,依此推測出急性束縛壓力可以在發炎疼痛模式的中樞促敏感期引發緊張所致止痛。第二,在腹腔或PAG注射選擇性拮抗劑去阻斷OX1R和CB1R可以抑制束縛壓力所致止痛。然而在PAG阻隔OX2R不會影響這種緊張所致止痛。這些結果推測出OX1R和CB1R被涵蓋在急性束縛壓力所引發的止痛效果,但OX2R則沒有。此外,我們也發現在未受束縛壓力的小鼠腹腔注射CB1R拮抗劑造成過度疼痛的狀況,但在PAG注射則沒有這樣的狀況。第三,naloxone在束縛壓力所致止痛沒有顯著影響,這表示內生性鴉片也許與緊張所致止痛無關。最後,對小鼠PAG注射食慾素A可減少福馬林實驗的第二期疼痛反應,而在PAG內注射OX1R和CB1R拮抗劑可以阻斷此現象。這表示在福馬林實驗中,vlPAG內的食慾素A可以和束縛壓力一樣,經由OX1R和CB1R產生止痛效果。我們先前的免疫組織化學實驗表示,相同的三十分鐘束縛壓力可以增加側下視丘的活化食慾素神經細胞數量。依這些結果可推測出在福馬林實驗中,側下視丘的活化食慾素神經細胞所釋放出的食慾素造成急性束縛壓力所致止痛。 綜合本篇論文和先前的電生理結果,可推測出在小鼠福馬林實驗第二期中,急性束縛壓力可引發緊張所致止痛,而此現象是經由活化側下視丘的食慾素神經細胞進而釋放食慾素去活化vlPAG內的OX1R,並透過位於vlPAG內生性大麻酯調控的逆行性去抑制機制,活化下行性疼痛抑制路徑。 | zh_TW |
dc.description.abstract | The orexin system consists of two neuropeptides (orexin A and orexin B) and two Gq-protein-coupled receptors (GqPCRs), orexin 1 receptor (OX1R) and orexin 2 receptor (OX2R). Orexin, also called hypocretin, the hypothalamic neuropeptides, has been known to be antinociceptive. Previously, we have found that activation of OX1R in the ventrolateral periaqueductal gray (vlPAG) can induce antinociception through the endocannabinoid, 2-arachidonoylglycerol (2-AG), engaging on the cannabinoid 1 receptor (CB1R) of presynaptic GABAergic terminals to inhibit GABA release, producing retrograde disinhibition in the PAG, which activates the descending pain inhibitory pathway.
Stress induced analgesia (SIA) is an evolutional protection mechanism for mammals in coping with stressful conditions. A wide variety of stressors can inhibit the responses of organisms to noxious painful stimuli. Acute restraint stress, one of the stressors to induce analgesia, has been reported to induce analgesia through an orexin-mediated mechansim. In our previous study, we have found that a 30-min restraint stress in mice induces analgesia in the hot-plate test and this SIA effect can be blocked by intra-vlPAG injection of the OX1R or CB1R antagonist. In this study, we examined if in the formalin test, a pain model mediated by peripheral inflammation followed by a central sensitization mechanism, a 30-min restraint stress in mice can also induce analgesia, and this SIA is also regulated by orexins and endocannabinoids in the PAG. First, 30-min restraint stress in mice induced analgesic effect in the second phase of the formalin test, suggesting acute restraint stress can induce SIA in the central-sensitization phase of an inflammatory pain model. Second, blockade of OX1Rs or CB1Rs, either by i.p. or i.pag. injection of the selective antagonist suppressed restraint SIA. However, i.pag. blockade of OX2Rs did not affect this SIA. These suggest that OX1Rs and CB1Rs, but not OX2Rs, are involved in acute restraint stress-induced analgesic effect. Besides, we also found that i.p. but not i.pag., injection of the CB1R antagonist caused hyperalgesic effect in unrestrained mice. Third, naloxone had no significant effect on restraint SIA, suggesting endogenous opioids might not play a role in this SIA. Finally, i.pag. injection of orexin A in mice reduced the phase 2 nociceptive response in the formalin test and this effect was blocked by i.pag. injection of the OX1R or CB1Rs antagonist. This suggests that orexin A in the vlPAG can induce antinociception in the formalin test via OX1Rs and CB1Rs as did restraint stress. Our previous immunohistochemical study has shown that the same 30-min restraint stress can increase the number of activated orexin neurons in the lateral hypothalamus (LH). These results suggest that acute restraint SIA in the formalin test is caused by the orexins released from activated orexin neurons in the LH. Taken together, the results in this study and previous eletrophysiological results, it is suggested that acute restraint stress can induce SIA in the second phase of the formalin test in mice, and this SIA is mediated through activating the LH orexin neurons to release orexins that activate the OX1Rs in the vlPAG, resulting in activation of the descending pain inhibitory pathway through an endocannabinoid-mediated retrograde disinhibition mechanism in the vlPAG. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T03:52:02Z (GMT). No. of bitstreams: 1 ntu-104-R01443003-1.pdf: 5586748 bytes, checksum: f310d7c3017f05756e09281523c6c3c6 (MD5) Previous issue date: 2015 | en |
dc.description.tableofcontents | 口試委員會審定書 i
致謝 ii 中文摘要 iv Abstract vi 目錄 ix 圖目錄 x 表目錄 xi Introduction 1 Aim 9 Materials and Methods 10 Results 15 Discussion 28 Conclusions 39 Figures 40 Tables 58 References 64 | |
dc.language.iso | en | |
dc.title | 食慾素與內生性大麻酯在緊張所致止痛之貢獻:小鼠福馬林疼痛模式之研究 | zh_TW |
dc.title | Acute Restraint Stress-Induced Analgesia in the Mouse Formalin Test:Involvement of Orexin and Endocannabinoid | en |
dc.type | Thesis | |
dc.date.schoolyear | 103-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 黃玲玲,陳景宗,陳志成,簡伯武 | |
dc.subject.keyword | 食慾素,內生性大麻酯,止痛,小鼠,福馬林,疼痛,束縛壓力, | zh_TW |
dc.subject.keyword | Restraint,Stress-Induced Analgesia,Mouse,Formalin Test,Orexin,Endocannabinoid,SIA,stress,PAG, | en |
dc.relation.page | 77 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2015-01-16 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 藥理學研究所 | zh_TW |
顯示於系所單位: | 藥理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-104-1.pdf 目前未授權公開取用 | 5.46 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。